These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8180

  • 1. Successful bone marrow transplantation against mixed lymphocyte culture barrier.
    Feig SA, Opelz G, Winter HS, Falk PM, Neerhout RC, Sparkes R, Gale RP.
    Blood; 1976 Sep; 48(3):385-91. PubMed ID: 8180
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP, Dietrich M, Goldmann SF, Kristensen T, Fliedner TM, Abt C, Pflieger H, Flad HD, Kubanek B, Heimpel H.
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation between mixed leukocyte culture reactive siblings.
    Blume KG, Bross KJ, Chillar RK, Findley DO, Opelz G, Paladugu RR, Sharkoff D, Warner JA.
    Acta Haematol; 1978 Dec; 59(5):257-61. PubMed ID: 25554
    [Abstract] [Full Text] [Related]

  • 4. Experience with incompatible maternal donors for bone marrow transplantation.
    Feig SA, Falk PM, Neerhout RC, Sparkes R, Gale RP, Opelz G, Cline MJ, Fahey J, Smith G, Sarna G, Territo M, Young L, Langdon EA, Fawzi F.
    Blut; 1977 Jan; 34(1):1-10. PubMed ID: 12847
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic marrow transplantation for the treatment of leukaemia. A review.
    Alvegård TA, Herzig GP, Graw RG.
    Scand J Haematol; 1975 Nov; 15(4):287-305. PubMed ID: 789
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease.
    Filipovich AH, Ramsay NK, Arthur DC, McGlave P, Kim T, Kersey JH.
    Transplantation; 1985 Mar; 39(3):282-5. PubMed ID: 3156437
    [Abstract] [Full Text] [Related]

  • 7. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.
    DeGast GC, Mickelson EM, Beatty PG, Amos D, Sullivan KM, Schoch HG, Thomas ED, Hansen JA.
    Bone Marrow Transplant; 1992 Feb; 9(2):87-90. PubMed ID: 1533333
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation for acute leukemia using a histocompatible paternal donor.
    Blume KG, Bross KJ, Chillar RK, Findley DO, Fuerth JH, Paladugu RR, Sharkoff D, Warner JA.
    Acta Haematol; 1979 Feb; 61(2):80-4. PubMed ID: 33519
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D, Goldmann SF, Haas RJ, Dietrich M, Flad HD, Fliedner TM, Kleihauer E.
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Segall M, Noreen H, Edwins L, Haake R, Shu XO, Kersey J.
    Hum Immunol; 1996 Aug; 49(1):49-55. PubMed ID: 8839775
    [Abstract] [Full Text] [Related]

  • 12. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS, Storb R, Weiden PL, Thomas ED.
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.
    Sondel PM, Hank JA, Wendel T, Flynn B, Bozdech MJ.
    J Clin Invest; 1983 Jun; 71(6):1779-86. PubMed ID: 6223050
    [Abstract] [Full Text] [Related]

  • 15. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.
    Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL.
    Blood; 1977 Apr; 49(4):511-33. PubMed ID: 14751
    [Abstract] [Full Text] [Related]

  • 16. Graft-versus-host disease following sibling allogeneic bone marrow transplantation--the Singapore experience.
    Lim SH, Ong YW, Ng HW.
    Ann Acad Med Singap; 1989 May; 18(3):317-9. PubMed ID: 2528315
    [Abstract] [Full Text] [Related]

  • 17. Bone marrow transplantation for acute myeloblastic leukemia.
    Bortin MM, Rimm AA.
    JAMA; 1978 Sep 15; 240(12):1245-52. PubMed ID: 28425
    [Abstract] [Full Text] [Related]

  • 18. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases.
    McGlave PB, Beatty P, Ash R, Hows JM.
    Blood; 1990 Apr 15; 75(8):1728-32. PubMed ID: 2328322
    [Abstract] [Full Text] [Related]

  • 19. Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor.
    Sturfelt G, Lenhoff S, Sallerfors B, Nived O, Truedsson L, Sjöholm AG.
    Ann Rheum Dis; 1996 Sep 15; 55(9):638-41. PubMed ID: 8882135
    [Abstract] [Full Text] [Related]

  • 20. [Possibilities of finding identical HLA donor-recipient pairs for bone marrow transplantation].
    Buc M, Niks M, Bláha M, Steruská M, Mistrík M.
    Bratisl Lek Listy; 1990 Jul 15; 91(7):516-20. PubMed ID: 2145057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.